The cell banking outsourcing global market report 2024from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Cell Banking Outsourcing Market, 2024report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size – The cell banking outsourcing market size has grown rapidly in recent years. It will grow from $9.76 billion in 2023 to $11.19 billion in 2024 at a compound annual growth rate (CAGR) of 14.7%. The growth in the historic period can be attributed to the rise in the prevalence of chronic diseases, the increased number of government initiatives, regulatory support and guidelines, and the increase in the establishment of banking services.
The cell banking outsourcing market size is expected to see rapid growth in the next few years. It will grow to $19.51 billion in 2028 at a compound annual growth rate (CAGR) of 14.9%. The growth in the forecast period can be attributed to rising adoption of cellular products, growing demand for monoclonal antibodies, increasing adoption of stem cell therapies, rising geriatric population, and growing dependency on cell-based therapies. Major trends in the forecast period include product innovations, technological advancements, investments in research and development, and the collaboration between biotech companies and specialized cell banking services.
Order your report now for swift delivery @ https://www.thebusinessresearchcompany.com/report/cell-banking-outsourcing-global-market-report
Scope Of Cell Banking Outsourcing MarketThe Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Cell Banking Outsourcing Market Overview
Market Drivers -The rise in the burden of chronic diseases is expected to propel the growth of the cell banking outsourcing market going forward. Chronic diseases are long-lasting conditions that typically develop gradually and persist over an extended period. The rising prevalence of chronic diseases can be attributed to a combination of various factors, including lifestyle changes, aging populations, and genetic predispositions. Cell banking outsourcing plays a valuable role in advancing research and development efforts aimed at addressing chronic diseases by providing access to expertise, resources, and infrastructure that may not be available in-house. For instance, in July 2023, according to the Department of the Treasury, an Australia-based national treasury and financial department, in 2020–21, nearly half of Australians of all ages (46.6%) had one or more chronic diseases, and almost one in five (18.6%) had two or more chronic conditions. Therefore, the rise in the burden of chronic diseases is driving the growth of the cell banking outsourcing market.
Market Trends – Major companies operating in the cell banking outsourcing market are focusing on developing technologically advanced solutions, such as single-cell potency characterization platforms, to provide precise and detailed analysis of individual cell potency. A single-cell potency characterization platform is a sophisticated technology or set of methodologies designed to assess and measure the potency and functional capabilities of individual cells within a cell population. For instance, in January 2024, Cellply Srl, an Italy-based biotechnology company, launched VivaCyte, its flagship product and an end-to-end single-cell potency characterization platform that integrates potency analysis and immunophenotyping to streamline cell therapy research and development. VivaCyte is a fully automated, standalone platform with single-cell resolution, designed to reduce development times, costs, and risks by characterizing the complex functionality and mechanism of action of potential cellular immunotherapies rapidly and comprehensively. This platform enables rapid testing of multiple cell therapy candidates from various process options against multiple target tumor cells, providing reproducible immune cell characterization and single-cell functional characterization in a fraction of the time needed by existing analytical tools.
The cell banking outsourcing market covered in this report is segmented –
1) By Type: Master Cell Banking, Working Cell Banking, Viral Cell Banking
2) By Cell Type: Stem Cell Banking, Non-Stem Cell Banking
3) By Phase: Bank Storage, Bank Characterization And Testing, Bank Preparation
Get an inside scoop of the cell banking outsourcing market, Request now for Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15754&type=smp
Regional Insights – North America was the largest region in the cell banking outsourcing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell banking outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Key Companies – Major companies operating in the cell banking outsourcing market are Labcorp Drug Development, SGS Life Sciences, Lonza Group Ltd., WuXi AppTec, Charles River Laboratories, Sigma-Aldrich Co. Ltd., Covance Inc., Global Stem Inc., LifeCell, Cryoviva India, Sartorius AG, Bio Reliance, CordLife, Reliance Life Sciences, Cryo-Cell International Inc., Toxikon Corp., Cleancells, Clean Biologics, Texcell, PX’Therapeutics SA, Goodwin Biotechnology Inc., Transcell Biolife Pvt Ltd, Perfectus Biomed Limited, BioStorage Technologies Inc.
Table of Contents 1. Executive Summary2. Cell Banking Outsourcing Market Report Structure3. Cell Banking Outsourcing Market Trends And Strategies4. Cell Banking Outsourcing Market – Macro Economic Scenario5. Cell Banking Outsourcing Market Size And Growth…..27. Cell Banking Outsourcing Market Competitor Landscape And Company Profiles28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
